Abstract
Background: Hospitalizations of chronic dialysis patients have not been previously studied at a national level in Canada. Understanding the scope and variables associated with hospitalizations will inform measures for improvement. Objective: To describe the risk of all-cause and infection-related hospitalizations in patients on dialysis. Design: Retrospective cohort study using health care administrative databases. Setting: Provinces and territories across Canada (excluding Manitoba and Quebec). Patients: Incident chronic dialysis patients with a dialysis start date between January 1, 2005, and March 31, 2014. Patients with a prior history of kidney transplantation were excluded. Measurements: Patient characteristics were recorded at baseline. Dialysis modality was treated as a time-varying covariate. The primary outcomes of interest were all-cause and dialysis-specific infection-related hospitalizations. Methods: Crude rates for all-cause hospitalization and infection-related hospitalization were determined per patient year (PPY) at 7 and 30 days, and at 3, 6, and 12 months postdialysis initiation. A stratified, gamma-distributed frailty model was used to assess repeat hospital admissions and to determine the inter-recurrence dependence of hospitalizations within individuals, as well as the hazard ratio (HR) attributed to each covariate of interest. Results: A total of 38 369 incident chronic dialysis patients were included: 38 088 adults and 281 pediatric patients (age less than 18 years). There were 112 374 hospitalizations, of which 11.5% were infection-related hospitalizations. The all-cause hospitalization rate was similar for all adult age groups (age 65 years and older: 1.40, 1.35, and 1.18 admissions PPY at 7 days, 30 days, and 6 months, respectively). The all-cause hospitalization rate was higher for pediatric patients (1.67, 2.48, and 2.47 admissions PPY at 7 days, 30 days, and 6 months, respectively; adjusted HR: 2.73, 95% confidence interval [CI]: 2.37-3.15, referent age group: 45-64 years). Within the first 7 days after dialysis initiation, patients on peritoneal dialysis had a higher risk of all-cause hospitalization (HR: 1.27, 95% CI: 1.07-1.50) and infection-related hospitalization (HR: 2.05, 95% CI: 1.19-3.55) compared with patients on hemodialysis. Beyond 7 days, the risk did not differ significantly by dialysis modality. Female sex and Indigenous race were significant risk factors for all-cause hospitalization. Limitations: The cohort had too few home hemodialysis patients to examine this subgroup. The outcome of infection-related hospitalization was determined using diagnostic codes. Dialysis patients from Manitoba and Quebec were not included. Conclusions: In Canada, the rates of hospitalization were not influenced by dialysis modality beyond the initial 7-day period following dialysis initiation; however, the rate of hospitalization in pediatric patients was higher than in adults at every time frame examined.
Original language | English |
---|---|
Journal | Canadian Journal of Kidney Health and Disease |
Volume | 5 |
DOIs | |
Publication status | Published - Jun 1 2018 |
Bibliographical note
Funding Information:We would like to acknowledge Naisu Zhu along with the entire Expert Advisory Group for its invaluable advice on the report from the Canadian Institute for Health Information titled High Risk and High Cost: Focus on Opportunities to Reduce Hospitalizations of Dialysis Patients in Canada, 2016. We also acknowledge Frank Ivis, Kelvin Lam, Noura Redding, Greg Webster, Juliana Wu, and Susan Samuel for their important contributions. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Amber O. Molnar is supported by the KRESCENT Foundation. Manish M. Sood is supported by the Jindal Research Chair for the Prevention of Kidney Disease. All funders had no role in the study design, analysis, interpretation, or writing of the manuscript.
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Amber O. Molnar is supported by the KRESCENT Foundation. Manish M. Sood is supported by the Jindal Research Chair for the Prevention of Kidney Disease. All funders had no role in the study design, analysis, interpretation, or writing of the manuscript.
Publisher Copyright:
© The Author(s) 2018.
ASJC Scopus Subject Areas
- Nephrology